Chlorhydrate de prilocaïne Prilline de base de base de Prilocaïne USP
Prilocaine Hydrochloride | Prilocaine USP
Prilocaïne Hcl
prénom: Prilocaine Hydrochloride
n ° CAS: 1786-81-8
Formule moléculaire: C13H21ClN2O
Masse moléculaire: 256.77
EINECS Non: 217-244-0
Apparence: White Solid
Point de fusion: 168-170°C
Utilisation: Prilocaine is a local anesthetic of the amino amide type. In its injectable form (trade name Citanest), it is often used in dentistry. It is also often combined with lidocaine as a topical preparation for dermal anesthesia (lidocaine/prilocaine or EMLA), for treatment of conditions like paresthesia. As it has low cardiac toxicity, it is commonly used for intravenous regional anaesthesia .
Prilocaine Hydrochloride USP Pharm Materials Chemical Test Specification (COA) :
|
Nom de produit
|
Prilocaine hydrochloride
|
|
CAS
n ° CAS.
|
1786-81-8
|
Emballage extérieur
|
25kg
25kg
|
|
Date de production
|
2016.03.11
|
Durée de conservation
|
2018.03.10
|
|
Norme adoptée
|
USP36
USP36
|
|
Éléments d'analyse
|
spécification
|
Résultats
|
|
Description
|
Poudre cristalline blanche
|
Conforme
|
|
Solubilité
|
,,,
Freely soluble in water and in alcohol ,slightly soluble in chloroform,very slightly soluble in acetone; practically insoluble in ether
|
Conforme
|
|
Identification
|
By IR absorption,To match with working standard
|
Conforme
|
|
Identification
|
Should be positive response
|
Conforme
|
|
Identification
|
Should display the reaction of chloride differentiated
|
Conforme
|
|
Point de fusion
|
166~169ºC
166~169ºC
|
166~168ºC
166~168ºC
|
|
Perte au séchage
|
≤ 0.3%
≤ 0.3%
|
0.13%
0.13%
|
|
Résidus au feu
|
≤0,1%
≤0,1%
|
0.03%
0.03%
|
|
Heavy metals
|
≤0.002%
≤0.002%
|
<0.002%
<0.002%
|
|
Residual solvents
|
Should be to match with the standard
|
Conforme
|
|
Essai
|
99.0% ~101.0%()
99.0% ~101.0%(on the anhydrous basis )
|
99.46%
99.46%
|
|
Conclusion
|
Qualifié
|
